Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 Jan;43(1):1-11.
doi: 10.1128/AAC.43.1.1.

Antifungal peptides: novel therapeutic compounds against emerging pathogens

A J De Lucca  1 , T J Walsh
Affiliations
Review

Antifungal peptides: novel therapeutic compounds against emerging pathogens

A J De Lucca et al. Antimicrob Agents Chemother. 1999 Jan.
No abstract available

PubMed Disclaimer

References

    1. Abruzzo G K, Flattery A M, Gill C J, Long L, Smith J G, Krupa D, Pikounis V B, Kroop H, Bartizal K. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 1995;39:1077–1081. - PMC - PubMed
    1. Abruzzo G K, Flattery A M, Gill C J, Long L, Smith J G, Pikounis V B, Balkovec J M, Bouffard A F, Droponski J F, Rosen H, Kropp H, Bartizal K. Evaluation of the echinocandin antifungal MK-0991 (L-743,8872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 1997;41:2333–2338. - PMC - PubMed
    1. Alcouloumbre M S, Gharinoum M A, Ibrahim A S, Selsted M E, Edwards J E. Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro. Antimicrob Agents Chemother. 1993;37:2628–2632. - PMC - PubMed
    1. Ammons S, Aardalen K, Froebel S, Little R. Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1997. Efficacy of domain III peptide from bactericidal/permeability-increasing protein (BPI) in murine disseminated aspergillosis. abstr. B-16; p. 29.
    1. Appenzeller L, Lim E, Wong P, Fadem M, Motchinik P, Bakalinsky M, Little R. Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1996. In vivo fungicidal activity of optimized domain III peptides derived from bactericidal/permeability-increasing protein (BPI), abstr. F187; p. 132.